The Trump administration’s latest move to cancel congressionally approved spending raises a consequential question about Congress’s authority over federal funds. But the cancellation dispute is not itself a veto. The market asks whether Congress will override a Trump veto, while the packet does not identify a specific vetoed bill connected to the current spending fight. Those are related questions about the balance of power, but they should not be conflated.
The administration announced it would cancel almost $1 billion in approved spending through a contested pocket-rescission maneuver, according to CBS News. The process described in the report allows a president to propose rescissions, while giving Congress 45 legislative days to approve them. Because the announcement came late, funds could be withheld until they expired. The immediate issue is therefore whether approved funds will reach the programs for which Congress authorized them, and how effectively lawmakers can exercise their role in deciding federal spending.
The administration argues that the spending is unnecessary or harmful and that the pocket-rescission mechanism is permissible. The legal question remains unsettled in the account provided by CBS News: the Supreme Court allowed earlier cancellations of foreign-aid funds to proceed, but did not decide their legal merits. CBS also reported that the Government Accountability Office has called pocket rescissions illegal, citing Republican Sen. Susan Collins. Collins criticized the latest action and said she would work with colleagues to address it. Her statement indicates opposition, but does not establish what Congress will do or whether any effort will succeed.
Kalshi’s contract asking whether Congress will override a Trump veto before the end of the year places the probability at 7%, as of 12:54 p.m. ET on Sept. 28. Its price was unchanged over the past day and over the past week. Trading volume was 225 contracts traded over the last day, while the venue listed 4,487 contracts open. Those figures describe activity in the contract; they do not establish that a veto is pending or that Congress is preparing to act on the spending cancellations. A second contract, asking whether Congress will ever override a Trump veto, places the probability at 38%, as of 12:54 p.m. ET on Sept. 28. It recorded 0 contracts traded over the last day. The distinct time horizons do not resolve the missing connection between the market question and the current spending dispute.
The central uncertainty is whether either chamber will take up a response to the cancellations, and whether any response would secure enough support to become consequential. The packet reports criticism from Collins, but does not establish that other lawmakers will join her, that Congress will act, or that a measure would face a veto. Nor does the reported Supreme Court action settle the legal merits of the pocket-rescission approach. The market offers a reading of traders’ beliefs about a veto override, not an answer about the outcome of this spending fight. For readers, the distinction is important: the dispute concerns funds Congress approved, while the contract concerns overriding a veto. One may illuminate the broader question of institutional power without directly measuring the other.
